AXT (AXTI) has had the highest return between August 29, 2025 and February 25, 2026 by a small-cap US stock, returning 1,113.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
AXT (AXTI) | 8/29/2025 - 2/25/2026 | 1,113.84% |
Treehouse Foods (THS) | 8/29/2025 - 2/25/2026 | 625.81% |
Adlai Nortye Ltd American Depositary Shares (ANL) | 8/29/2025 - 2/25/2026 | 504.18% |
Ventyx Biosciences (VTYX) | 8/29/2025 - 2/25/2026 | 469.8% |
Tanzanian Royalty Exploration (TRX) | 8/29/2025 - 2/25/2026 | 425% |
PepGen (PEPG) | 8/29/2025 - 2/25/2026 | 418.03% |
Relmada Therapeutics (RLMD) | 8/29/2025 - 2/25/2026 | 413.25% |
RAPT Therapeutics (RAPT) | 8/29/2025 - 2/25/2026 | 402.43% |
Alto Neuroscience (ANRO) | 8/29/2025 - 2/25/2026 | 401.82% |
Armata Pharmaceuticals (ARMP) | 8/29/2025 - 2/25/2026 | 365.1% |
Olema Pharmaceuticals (OLMA) | 8/29/2025 - 2/25/2026 | 347.28% |
Capricor Therapeutics (CAPR) | 8/29/2025 - 2/25/2026 | 344.43% |
BioAge Labs (BIOA) | 8/29/2025 - 2/25/2026 | 343.62% |
Babcock & Wilcox Enterprises (BW) | 8/29/2025 - 2/25/2026 | 333.02% |
T1 Energy (TE) | 8/29/2025 - 2/25/2026 | 332.32% |
Nautilus Biotechnology (NAUT) | 8/29/2025 - 2/25/2026 | 311.59% |
Monte Rosa Therapeutics (GLUE) | 8/29/2025 - 2/25/2026 | 296.08% |
Almonty Industries Inc Common Shares (ALM) | 8/29/2025 - 2/25/2026 | 272.58% |
Immix Biopharma (IMMX) | 8/29/2025 - 2/25/2026 | 269.45% |
Burning Rock Biotech (BNR) | 8/29/2025 - 2/25/2026 | 231.69% |
Corvus Pharmaceuticals (CRVS) | 8/29/2025 - 2/25/2026 | 228.78% |
Hotel101 Global Holdings Corp Class A Ordinary Shares (HBNB) | 8/29/2025 - 2/25/2026 | 228.57% |
Zura Bio Limited - Class A Ordinary shares (ZURA) | 8/29/2025 - 2/25/2026 | 215.57% |
Kodiak Sciences (KOD) | 8/29/2025 - 2/25/2026 | 210.89% |
Ichor (ICHR) | 8/29/2025 - 2/25/2026 | 208.11% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
